SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 353,992.81 |
Enterprise Value ($M) | 369,763.81 |
Book Value ($M) | 71,538.00 |
Book Value / Share | 29.71 |
Price / Book | 4.95 |
NCAV ($M) | -54,880.00 |
NCAV / Share | -22.79 |
Price / NCAV | -6.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.14 |
Return on Assets (ROA) | 0.09 |
Return on Equity (ROE) | 0.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.79 |
Current Ratio | 1.03 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 53,249.00 |
Assets | 178,287.00 |
Liabilities | 108,129.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.53 | -7.07 | |
13G/A | State Street Corp | 5.52 | -6.64 | |
13G/A | BlackRock, Inc. | 7.70 | -6.28 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,416,991 | 8,243,825 | 17.19 | |
1,138,446 | 7,385,827 | 15.41 | |
1,525,044 | 7,247,968 | 21.04 | |
(click for more detail) |
Similar Companies | |
---|---|
EBS – Emergent BioSolutions Inc. | ELAN – Elanco Animal Health Incorporated |
HYAC – Haymaker Acquisition Corp. 4 | LLY – Eli Lilly and Company |
MRK – Merck & Co., Inc. |